Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.726428
Abstract: B cell depleting therapies permit immunosuppressive drug withdrawal and maintain remission in patients with frequently relapsing nephrotic syndrome (FRNS) or steroid–dependent nephrotic syndrome (SDNS), but lack of biomarkers for treatment failure. Post-depletion immune cell reconstitution…
read more here.
Keywords:
class switched;
cytof enabled;
cell;
nephrotic syndrome ... See more keywords